Jon Fernandez is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Aug 2024: GelSana Therapeutics, Inc. (Aurora, CO — biotechnology — 2024; $4.35M reported sold to 33 investors).
What this means One deal on file with the SEC, filed Aug 2024. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Diana Verrilli (1 shared filing), Melissa Krebs (1 shared filing) and Mike Freeman (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jon. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Jon Fernandez and found 2 differences, 1 worth asking the sponsor about: Jon Fernandez is no longer listed on the Mar 6, 2026 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.